MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

Search

STERIS PLC

Open

SectorHealthcare

222.65 -1.59

Overview

Share price change

24h

Current

Min

222.11

Max

228.11

Key metrics

By Trading Economics

Income

16M

173M

Sales

42M

1.4B

P/E

Sector Avg

36.498

63.778

EPS

2.32

Dividend yield

1.01

Profit margin

12.643

Employees

18,000

EBITDA

-85M

245M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+16.45% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

1.01%

2.39%

Next Earnings

7 May 2025

Next Dividend date

25 Jun 2025

Next Ex Dividend date

11 Jun 2025

Market Stats

By TradingEconomics

Market Cap

22B

Previous open

224.24

Previous close

222.65

News Sentiment

By Acuity

26%

74%

73 / 386 Healthcare

Technical Score

By Trading Central

Confidence

Strong Bullish Evidence

STERIS PLC Chart

Past performance is not a reliable indicator of future results.

Related News

5 Feb 2025, 21:35 UTC

Earnings

Steris: Outlook Does Not Reflect Any Potential Impact From New Tariffs >STE

5 Feb 2025, 21:34 UTC

Earnings

Steris: FY25 Guidance Change Is Primarily Due to Currency >STE

5 Feb 2025, 21:34 UTC

Earnings

Steris Cuts FY25 Revenue View to Increase of About 6% From Prior View for 6.5%-7%>STE

5 Feb 2025, 21:33 UTC

Earnings

Steris 3Q EPS $1.75 >STE

5 Feb 2025, 21:30 UTC

Earnings

Steris Sees FY Adj EPS $9.05-Adj EPS $9.15 >STE

5 Feb 2025, 21:30 UTC

Earnings

Steris 3Q Rev $1.4B >STE

5 Feb 2025, 21:30 UTC

Earnings

Steris 3Q Adj EPS $2.32 >STE

6 Nov 2024, 21:41 UTC

Earnings

Steris Backs FY25 Revenue Up 6.5%-7.5% >STE

6 Nov 2024, 21:40 UTC

Earnings

Steris 2Q EPS $1.51 >STE

6 Nov 2024, 21:30 UTC

Earnings

Steris Sees FY Adj EPS $9.05-Adj EPS $9.25 >STE

6 Nov 2024, 21:30 UTC

Earnings

Steris 2Q Adj EPS $2.14 >STE

6 Nov 2024, 21:30 UTC

Earnings

Steris 2Q Rev $1.3B >STE

6 Aug 2024, 20:36 UTC

Earnings

Steris 1Q Adj EPS $2.03 >STE

6 Aug 2024, 20:30 UTC

Earnings

Steris 1Q Net $139.9M >STE

6 Aug 2024, 20:30 UTC

Earnings

Steris 1Q EPS $1.41 >STE

6 Aug 2024, 20:30 UTC

Earnings

Steris Sees FY Adj EPS $9.05-Adj EPS $9.25 >STE

3 Jun 2024, 11:03 UTC

Acquisitions, Mergers, Takeovers

PEAK ROCK Cap Affil COMPLETES PREVIOUSLY ANNOUNCED ACQUISITION of HUFRIEDYGROUP

31 May 2024, 20:47 UTC

Acquisitions, Mergers, Takeovers

Steris Completes $787.5M Sale of Dental Segment to Peak Rock Capital

8 May 2024, 20:40 UTC

Earnings

Steris Sees FY25 Adj EPS $9.05-Adj EPS $9.25 >STE

8 May 2024, 20:39 UTC

Earnings

Steris: Plan Includes Restructuring of the Healthcare Surgical Business in Europe >STE

8 May 2024, 20:39 UTC

Earnings

Steris Announcing a Targeted Restructuring Plan >STE

8 May 2024, 20:39 UTC

Earnings

Steris 4Q EPS $3.81 >STE

8 May 2024, 20:30 UTC

Earnings

Steris 4Q Adj EPS $2.58 >STE

11 Apr 2024, 11:01 UTC

Acquisitions, Mergers, Takeovers

Steris Expects Resulting Benefit of Reduction in Interest Expense to Be About $0.35 Per Shr >STE

11 Apr 2024, 11:00 UTC

Acquisitions, Mergers, Takeovers

Steris: Transaction Is Anticipated to Close in 1Q of Fiscal Yr 2025 >STE

11 Apr 2024, 10:59 UTC

Acquisitions, Mergers, Takeovers

Steris: Transaction Terms Include Opportunity to Receive Additional Earnout of Up to $12.5M >STE

11 Apr 2024, 10:59 UTC

Acquisitions, Mergers, Takeovers

Steris: Transaction Is Structured as Equity Sale >STE

11 Apr 2024, 10:58 UTC

Acquisitions, Mergers, Takeovers

Steris Enters Agreement to Divest Dental Segment to Peak Rock Cap for $787.5M >STE

11 Apr 2024, 10:58 UTC

Acquisitions, Mergers, Takeovers

STERIS to Sell Dental Segment to an Affiliate of Peak Rock Capital for $787.5M

Peer Comparison

Price change

STERIS PLC Forecast

Price Target

By TipRanks

16.45% upside

12 Months Forecast

Average 265 USD  16.45%

High 265 USD

Low 265 USD

Based on 3 Wall Street analysts offering 12 month price targets forSTERIS PLC - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

3 ratings

2

Buy

1

Hold

0

Sell

Technical Score

By Trading Central

222.25 / 228.22Support & Resistance

Short Term

Strong Bullish Evidence

Intermediate Term

Strong Bullish Evidence

Long Term

Weak Bullish Evidence

Sentiment

By Acuity

73 / 386 Healthcare

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About STERIS PLC

STERIS plc provides infection prevention products and services worldwide. It operates through three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument, devices, and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The AST segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of contract sterilization and laboratory facilities, as well as integrated sterilization equipment and control systems to medical device manufacturers and research institutions. The Life Sciences segment designs, manufactures, and sells consumable products, such as pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. It serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is headquartered in Mentor, Ohio.